Inogen (NASDAQ:INGN - Get Free Report) is projected to issue its Q1 2025 quarterly earnings data after the market closes on Wednesday, May 7th. Analysts expect the company to announce earnings of ($0.52) per share and revenue of $79.57 million for the quarter.
Inogen Trading Up 2.0 %
Shares of NASDAQ:INGN traded up $0.14 on Friday, reaching $7.20. 124,221 shares of the company were exchanged, compared to its average volume of 238,609. The company has a 50-day moving average of $7.30 and a 200-day moving average of $8.99. The firm has a market cap of $193.59 million, a price-to-earnings ratio of -3.20 and a beta of 1.48. Inogen has a 1-year low of $6.40 and a 1-year high of $13.33.
Analyst Ratings Changes
Several brokerages have recently commented on INGN. Needham & Company LLC reissued a "hold" rating on shares of Inogen in a research note on Wednesday, April 9th. StockNews.com cut Inogen from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th.
Read Our Latest Report on INGN
About Inogen
(
Get Free Report)
Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Featured Stories
Before you consider Inogen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inogen wasn't on the list.
While Inogen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
